Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E C Petrella"'
Publikováno v:
The Journal of Immunology. 153:2213-2221
The sequential molecular events of the initiation, amplification, and membrane attack phases of classical C pathway activation on nucleated cells were investigated. As a model system, C-susceptible human melanoma cells (SK-MEL-93-2) expressing the di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e94819a9a3a9ed8f8719702c2469310
https://doi.org/10.4049/jimmunol.153.5.2213
https://doi.org/10.4049/jimmunol.153.5.2213
Publikováno v:
The Journal of Immunology. 152:2977-2986
Cobra venom factor (CVF) is the nontoxic C-activating glycoprotein in cobra venom. It is a structural and functional analogue of complement component C3. Previous work has established that the major oligosaccharide chain of CVF is a symmetric fucosyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a7aebae446244dcc20fee3771b570a3
https://doi.org/10.4049/jimmunol.152.6.2977
https://doi.org/10.4049/jimmunol.152.6.2977
Autor:
M W Ollert, R Frade, A Fiandino, M Panneerselvam, E C Petrella, M Barel, M K Pangburn, R Bredehorst, C W Vogel
Publikováno v:
The Journal of Immunology. 144:3862-3867
Human melanoma cells resistant to killing by the R24 mAb and human complement rapidly degrade surface-deposited C3b (M. Panneerselvam, S. Welt, L. J. Old, C.-W. Vogel. 1986. J. Immunol. 136:2534). We report that C-resistant melanoma cells express a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d4e52df52856d91bc8dca0ef21dff9a
https://doi.org/10.4049/jimmunol.144.10.3862
https://doi.org/10.4049/jimmunol.144.10.3862
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 152(6)
Cobra venom factor (CVF) is the nontoxic C-activating glycoprotein in cobra venom. It is a structural and functional analogue of complement component C3. Previous work has established that the major oligosaccharide chain of CVF is a symmetric fucosyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00fa5987cb2bfefb05add1fff73debc0
https://pubmed.ncbi.nlm.nih.gov/8144897
https://pubmed.ncbi.nlm.nih.gov/8144897
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 149(11)
Complement component C3 is a multifunctional protein known to interact specifically with more than 10 different plasma proteins or cell surface receptors. Cobra venom contains cobra venom factor, a structural analogue of C3 that shares some propertie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1a35a90be90fe763bba4629c52da760
https://pubmed.ncbi.nlm.nih.gov/1431125
https://pubmed.ncbi.nlm.nih.gov/1431125
Publikováno v:
Journal of immunological methods. 104(1-2)
Immunoconjugates are semi-synthetic hybrid proteins which bear great promise to become a new generation of anti-tumor agents. While many immunoconjugates have been shown to be selectively cytotoxic in in vitro model systems, dramatic in vivo anti-tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::561940a848dd496b7975d915d6277bb1
https://pubmed.ncbi.nlm.nih.gov/3500233
https://pubmed.ncbi.nlm.nih.gov/3500233